Two new flavonoids, bakuisoflavone (1) and bakuflavanone (2), together with 15 known compounds, were isolated from the fruits of Psoralea corylifolia, and their structures were characterized by spectroscopic data. The effects of the isolated compounds on methicillin-resistant Staphylococcus aureus were also examined. We found that two compounds, isobavachalcone (10) and bakuchiol (12), showed noticeable antibacterial effects on the MRSA strains examined. Quantitation of the major constituents, including anti-MRSA constituents, was then performed. The results showed individual contents of 1.26%-16.49% (w/w) among the examined compounds in the ethyl acetate extract from P. corylifolia fruits.
Introduction
Psoralea corylifolia L. (Fabaceae) is a plant species indigenous to China. Fruits of this plant have been used traditionally for various diseases, including gynecological bleeding, vitiligo and psoriasis.
OPEN ACCESS
A number of chemical constituents, including flavonoids and coumarins, have been isolated from this plant. Some of these compounds exhibit antioxidant [1] , antiplatelet [2] , estrogenic [3] , immunomodulatory, and antitumor properties [4] . Antibacterial effects of several constituents on Staphylococcus aureus and S. epidermidis [5] have been reported. A previous report showed that bakuchiol, the main constituent, was also effective on methicillin-resistant S. aureus (MRSA) [6] .
Staphylococcus aureus causes a variety of human diseases, ranging from minor skin infections to severe sepsis, and MRSA has become one of the most frequently encountered antibiotic-resistant bacteria [7] . Several prenylated phenolics obtained from licorice have shown noticeable antibacterial effects on MRSA [8] . Since a number of prenylflavonoids and related compounds were isolated from P. corylifolia [5, 9, 10] , this plant species is expected to be a resource of lead compounds for new anti-MRSA drugs.
Our preliminary research showed that P. corylifolia fruit extract exhibited remarkable antibacterial effects on MRSA. Therefore, we scrutinized the fruit constituents and isolated 17 compounds, including two new ones, and found that several compounds showed potent antibacterial activity on MRSA. This paper describes the structures of the new compounds, as well as the antibacterial effects of the phenolic constituents on MRSA.
Results and Discussion
Column chromatography of the ethyl acetate extract obtained from the fruits of P. corylifolia on silica gel, Sephadex LH-20 and MCI gel CHP-20P, and further purification of the fractions by preparative high performance liquid chromatography (HPLC) and thin layer chromatography (TLC), were performed to yield 17 phenolic compounds. Among them, the following 15 were identified as known compounds by comparison of their spectral data with those in the literature: corylifol C (3) [5] , bavachinin (4) [11] , bavachin (5) [12] , neobavaisoflavone (6) [11] , corylin (7) [13] , corylifol A (8) [5] , 8-prenyldaidzin (9) [14, 15] , isobavachalcone (10) [11] , corylifol B (11) [5] , bakuchiol (12) (16) [18] , and isopsoralen (17) [19] (Figure 1 ). The remaining two compounds were regarded as novel and named bakuisoflavone (1) and bakuflavanone (2) (Figure 1 ). Their structures were characterized as follows.
Structure Elucidation of the Novel Compounds
Bakuisoflavone (1) was obtained as a pale yellow amorphous powder. High-resolution fast-atom bombardment mass spectroscopy (HR-FABMS) revealed the molecular formula C20H19O5 by the [M + H] + ion at m/z 339.1219. The UV spectrum of 1 showed absorption maxima at 248 and 304 nm, suggesting its isoflavone nature [20] . The Figures S2 and S3) showed 20 carbon signals, corresponding to 15 carbons of the 4′,7-dihydroxy isoflavone structure and to five carbons of the 2-hydroxyl-3-methyl-3-butenyl moiety ( Table 1 ). The HMBC spectrum ( Figure S4) showed correlations of H-1′′ of the C5 (2-hydroxy-3-methyl-3-butenyl) moiety to C-2′ and C-4′, and those of H-2′′ to C-3′, indicating the location of the C5 unit at C-3′ on the isoflavone skeleton ( Figure 2 ). The structure of bakuisoflavone (1) was thus elucidated to be 4′,7-dihydroxy-3′-(2-hydroxy-3-methyl-3-butenyl)-isoflavone. Since this compound was optically inactive, the formation of an enantiomeric mixture at C-2′′ was assumed. (Table 1 ). In the HMBC spectrum (Figures 2 and S8) , correlations between H-1′′ of the C5 (2-hydroxy-3-methyl-3-butenyl moiety) unit to the C-5, C-6, and C-7 signals of the flavanone skeleton indicated that this C5 unit is located at C-6. Bakuflavanone (2) was thus characterized to be 4′,7-dihydroxy-6-(2-hydroxy-3-methyl-3-butenyl)-flavanone. The duplication of NMR signals was attributed to racemization at one of the asymmetric centers. The circular dichroism (CD) spectrum of this compound showed a prominent negative Cotton effect at ~306 nm, indicating the S configuration at C-2. Therefore, this compound was determined to form a mixture at the C-2′′asymmetric center.
Antibacterial Effects of Isolated Compounds
The antibacterial effects of the compounds isolated from P. corylifolia on MRSA were examined by the liquid dilution method [23] . Minimum inhibitory concentrations (MIC) of the tested compounds are shown in Table 2 .
Flavone and Flavanones
Among the compounds examined, only one flavone, corylifol (3), exerted an antibacterial effect on the two MRSA strains (MIC 16 µg/mL). One of the flavanones, bavachin (5), showed a lesser antibacterial effect (MIC 32 µg/mL), while other flavanones, bakuflavanone (2) and bavachinin (4), did not exhibit antibacterial effects at the concentrations examined.
Isoflavones and Chalcones
Most of the isoflavones showed negligible antibacterial effects (MICs > 32 µg/mL), except for neobavaisoflavone (6) , which showed an MIC of 16 µg/mL. Two chalcones, isobavachalcone (10) and corylifol B (11), showed notable antibacterial effects on MRSA (MIC 8 or 16 µg/mL).
Meroterpenes and Coumarins
Bakuchiol (12) , one of the phenolic meroterpenes, showed a remarkable antibacterial effect (MIC, 8 µg/mL), while the other meroterpenes, 13-15, and coumarins, 16 and 17, showed negligible effects. 
Structure-Activity Relationships
Previous studies have shown that bakuchiol (12) and isobavachalcone (10) exhibit antibacterial effects on MRSA [24, 25] , and the present study also showed antibacterial effects of these two on MRSA OM481 and OM584 strains. On the other hand, compounds 13-15, each of which is oxidized at the terminal prenyl group, showed weaker antibacterial effects than that observed for bakuchiol (12) , which is unoxidized at the terminal prenyl group. Similarly, bakuisoflavone (1) and bakuflavanone (2) , in which the prenyl group is oxidized to 2-hydroxy-3-methyl-3-butenyl group in each structure, showed weaker antibacterial effects than those of the corresponding unoxidized compounds, bavachin (5) and neobavaisoflavone (6) . Therefore, we assumed that hydroxylation of the prenyl group weakened the antibacterial effects. Bavachinin (4), in which the hydroxy group at C-7 in bavachin (5) is substituted with a methoxyl group, showed a weaker antibacterial effect relative to that of compound 5. This comparison suggests the importance of the presence of the phenolic hydroxyl group in the flavonoid skeleton.
Based on these observations, we concluded that the presence of both phenolic hydroxy groups and the lipophilicity due to the benzene rings and the prenyl group are required for the potent antibacterial effects on MRSA, and these may contribute to the interaction of the compounds at bacterial cell membranes. Analogous observations have also been reported on the effects of licorice phenolics on MRSA [8] and on vancomycin-resistant Enterococci (VRE) [26] [27] [28] .
Quantitative Analysis of the Major Constituents in P. corylifolia Fruit Extract
In the present study, several anti-MRSA constituents were found in P. corylifolia fruits, indicating that this plant may be a valuable resource for lead compound development of anti-MRSA drugs. To evaluate the usefulness of this plant, quantitative analysis of the antibacterial constituents was performed. Ethyl acetate extract from P. corylifolia was used for HPLC analysis. Quantitation of the major constituents, including anti-MRSA constituents, was based on UV absorption at 280 nm.
The results are summarized in Table 3 . Among the peaks caused by constituents (Figure 3 ), isobavachalcone (10) (peak 10) and bakuchiol (12) (peak 12) showed especially potent anti-MRSA effects. Among the estimated compounds, bakuchiol (12) has the highest ethyl acetate extract content. This observation is in accord with the fact that this compound, a typical meroterpene composed of a phenolic structure and a monoterpene structure, was isolated as the major constituent from P. corylifolia [29] . The bavachinin (4) content, which is biogenetically derived from bavachin (5), was much higher than its mother compound, 5. The chalcones isobavachalcone (10) and corylifol B (11) also showed high contents in the extract. These results shown in the present study suggested that the HPLC method can be utilized for quality control with respect to the antibacterial resource. (4) 5.03 ± 0.100 Bavachin (5) 1.80 ± 0.059 Neobavaisoflavone (6) 2.33 ± 0.054 Corylifol A (8) 1.86 ± 0.046 Isobavachalcone (10) 3.14 ± 0.111 Corylifol B (11) 1.81 ± 0.121 Bakuchiol (12) 16.49 ± 0.455 Psoralen (16) 1.76 ± 0.052 Isopsoralen (17) 1.26 ± 0.071 a The value was given as the mean ± standard deviation (SD) based on the triplicate experiments. The indicated number of each peak is corresponding to the compound number displayed in Figure 1 . 
Experimental Section

General Information
Isolation of Compounds from P. corylifolia
P. corylifolia powder (750 g) was extracted in n-hexane (3 L × 3), ethyl acetate (3 L × 3) and methanol (3 L × 3), successively. The ethyl acetate extract (22 g) was subjected to silica gel (YMC SIL) (30 mm i.d. × 480 mm) to yield 34 fractions (SIL1-SIL34). SIL5 was identified as bakuchiol (12) (576.9 mg). Crystallization of SIL11 and SIL16 from n-hexane/EtOAc resulted in psoralen (16) (16.5 mg) and isopsoralen (17) (57.1 mg), respectively. SIL18 was chromatographed on Sephadex LH-20 and further purified by preparative TLC on silica gel and preparative HPLC on YMC-PACK SIL-A024 (10 mm i.d. × 300 mm) with n-hexane/EtOAc (3:1) to yield 3-hydroxy-Δ 1 -bakuchiol (13) (15.9 mg) and bavachinin (4) (36.9 mg). Column chromatography of SIL20 on silica gel, followed by purification by preparative HPLC on YMC-PACK SIL-A024 (10 mm i.d. × 300 mm) with n-hexane/EtOAc (3:1) yielded 2-hydroxy-Δ 3 -bakuchiol (14) (13.0 mg). SIL24 was chromatographed repeatedly on YMC SIL followed by Sephadex LH-20 and further purified by preparative HPLC on YMC SIL-A024 (10 mm i.d. × 300 mm) with n-hexane/EtOAc (3:1) to give corylin (7) (5.0 mg), isobavachalcone (10) (19.2 mg) and bavachin (5) (21.7 mg). SIL31 and SIL32 were combined and chromatographed on YMC SIL followed by Sephadex LH-20 to give corylifol A (8) (11.4 mg) and neobavaisoflavone (6) (163.1 mg), respectively. SIL34 was subjected to column chromatography on MCI gel CHP-20P followed by Sephadex LH-20, and the main constituent was further purified by preparative TLC on silica gel followed by preparative HPLC on YMC SIL-A024 with n-hexane/EtOAc (3:2) followed by YMC ODS-A324 (10 mm i.d. × 300 mm) with MeOH/H2O (7:3) to yield 8-prenyldaidzein (9) (22.8 mg), 12,13-diolbakuchiol (15) (27.6 mg), corylifol B (11) (19.5 mg), corylifol C (3) (5.7 mg), bakuisoflavone (1) (9.2 mg), and bakuflavanone (2) (4.6 mg).
Compound Characterization
Bakuisoflavone ( (Table 1) .
Antibacterial Assay
Two strains of MRSA, OM481 and OM584, clinical isolates from Okayama University Hospital that were stored in a Department of Microbiology laboratory, were used in this study. MICs were estimated by a liquid dilution method. Briefly, tested sample solutions of compounds 1-17 were diluted two-fold serially, and pre-cultured bacterial solutions were mixed on 96-well plates and incubated at 37 °C for 24 h. The lowest concentration among the tested samples at which the visible growth was completely inhibited was regarded as the MIC.
Quantitative Analysis of the Major Constituents in P. corylifolia Fruit Extract
Quantitative analysis of the constituents of the P. corylifolia fruit extract was carried out on a 5, 6, 8, 10, 11, 12, 16 and 17) , used as the external standards, were prepared in series (from 0.01 to 1.00 mg/mL) and 2 µL each of the solutions were applied to HPLC, to produce nine individual regression lines to give equations shown in Table 4 . Under these HPLC conditions, the relative standard deviation (RSD) 3.7% of the peak area was observed for eight injections of the solution of isopsoralen (17) . The MeOH solution of the EtOAc extract of P. corylifolia fruit (1 mg/mL, 2 µL) was applied to the HPLC analysis, and three independent experiments were conducted for the quantitation of the nine constituents in the extract. The characters x and y represent the amount of the compound injected and the relative peak area shown by the data processor of the HPLC system, respectively. 
Conclusions
In the present study, 17 compounds were isolated from the ethyl acetate extract of P. corylifolia. Among these compounds, two new compounds, bakuisoflavone (1) and bakuflavanone (2) , were elucidated to be 4′,7-dihydroxy-3′-(2-hydroxy-3-methyl-3-butenyl)-isoflavone and 4′,7-dihydroxy-3′-(2-hydroxy-3-methyl-3-butenyl)-flavanone, respectively. The antibacterial effects of the isolated compounds, which were categorized as a flavone (3), flavanones (2, 4 and 5), isoflavones (1, 6, 7, 8 and 9), chalcones (10 and  11), meroterpenes (12, 13, 14 and 15), and coumarins (16 and 17) , were examined. Among them, isobavachalcone (10) and bakuchiol (12) showed significant anti-MRSA effects. Corylifol C (3), neobavaisoflavone (6) and corylifol B (11) also showed potent antibacterial effects. According to quantitative analysis, these effective compounds are all highly present in P. corylifolia. These findings suggest that this plant may be a promising resource for lead compound development of anti-MRSA drugs.
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